|
 |
News
- FDA Approves Abbott's XIENCE™ V Drug Eluting Stent
- Abbott Hosts Conference Call for Second-Quarter Earnings
- Earvin "Magic" Johnson and Abbott Bring "I Stand with Magic" Program: Part of the Campaign to End Black HIV/AIDS to Facebook Community
Features
|
XIENCE™ V Wins United States Approval The FDA has approved our XIENCE V drug eluting stent for treatment of coronary artery disease. It will launch in the United States immediately and is expected to become a significant contributor to Abbott’s future performance. |
|
"I Stand with Magic" Public Service Announcements The “I Stand With Magic Program: Part of the Campaign to End Black AIDS,” in partnership with local communities, provides free and confidential HIV testing. Knowing your status and seeking treatment are the first steps in fighting this disease. |
|
Abbott Responds to Disasters in Myanmar and China Abbott and its philanthropic foundation the Abbott Fund are providing U.S. $1.5 million in humanitarian aid in response to the earthquake in Sichuan Province in China and Cyclone Nargis in Myanmar. |
|
Abbott Presents New Approach for Treating Attention-Deficit Hyperactivity Disorder Attention-Deficit Hyperactivity Disorder (ADHD), an ailment historically associated with childhood, persists into adulthood in more than two-thirds of cases. While medical treatment can improve the symptoms of ADHD, currently approved treatments often cause undesirable side effects, including increases in heart rate and blood pressure. |
